These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16540942)

  • 1. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study.
    Glass TR; De Geest S; Weber R; Vernazza PL; Rickenbach M; Furrer H; Bernasconi E; Cavassini M; Hirschel B; Battegay M; Bucher HC
    J Acquir Immune Defic Syndr; 2006 Mar; 41(3):385-92. PubMed ID: 16540942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy.
    Sullivan PS; Campsmith ML; Nakamura GV; Begley EB; Schulden J; Nakashima AK
    PLoS One; 2007 Jun; 2(6):e552. PubMed ID: 17579723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported nonadherence with antiretroviral drugs predicts persistent condition.
    Murri R; Ammassari A; De Luca A; Cingolani A; Marconi P; Wu AW; Antinori A
    HIV Clin Trials; 2001; 2(4):323-9. PubMed ID: 11590535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome.
    DeMasi RA; Graham NM; Tolson JM; Pham SV; Capuano GA; Fisher RL; Shaefer MS; Pakes GE; Sawyerr GA; Eron JJ
    Adv Ther; 2001; 18(4):163-73. PubMed ID: 11697019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project.
    Johnson MO; Catz SL; Remien RH; Rotheram-Borus MJ; Morin SF; Charlebois E; Gore-Felton C; Goldsten RB; Wolfe H; Lightfoot M; Chesney MA;
    AIDS Patient Care STDS; 2003 Dec; 17(12):645-56. PubMed ID: 14746658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric Disorders, Antiretroviral Medication Adherence and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults.
    Bucek A; Leu CS; Benson S; Warne P; Abrams EJ; Elkington KS; Dolezal C; Wiznia A; Mellins CA
    Pediatr Infect Dis J; 2018 Jul; 37(7):673-677. PubMed ID: 29227462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study.
    Stone VE; Hogan JW; Schuman P; Rompalo AM; Howard AA; Korkontzelou C; Smith DK;
    J Acquir Immune Defic Syndr; 2001 Oct; 28(2):124-31. PubMed ID: 11588505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
    Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
    PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients.
    Maggiolo F; Ripamonti D; Arici C; Gregis G; Quinzan G; Camacho GA; Ravasio L; Suter F
    HIV Clin Trials; 2002; 3(5):371-8. PubMed ID: 12407486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated With Nonadherence to Antiretroviral Therapy Among Young People Living With Perinatally Acquired HIV in England.
    Judd A; Melvin D; Thompson LC; Foster C; Le Prevost M; Evangeli M; Winston A; Arenas-Pinto A; Sturgeon K; Rowson K; Gibb DM; Castro H
    J Assoc Nurses AIDS Care; 2020; 31(5):574-586. PubMed ID: 32467489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients.
    Garcia R; Badaró R; Netto EM; Silva M; Amorin FS; Ramos A; Vaida F; Brites C; Schooley RT
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1248-52. PubMed ID: 17209767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality.
    Glass TR; Sterne JA; Schneider MP; De Geest S; Nicca D; Furrer H; Günthard HF; Bernasconi E; Calmy A; Rickenbach M; Battegay M; Bucher HC;
    AIDS; 2015 Oct; 29(16):2195-200. PubMed ID: 26544582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy.
    Heath KV; Singer J; O'Shaughnessy MV; Montaner JS; Hogg RS
    J Acquir Immune Defic Syndr; 2002 Oct; 31(2):211-7. PubMed ID: 12394800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to Antiretroviral Therapy in Turkey: Results from the ACTHIV-IST Study Group.
    Yildiz Sevgi D; Gunduz A; Altuntas Aydin O; Mete B; Sargin F; Kumbasar Karaosmanoglu H; Uzun N; Yemisen M; Dokmetas I; Tabak F
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1192-1198. PubMed ID: 28854809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of selective ritonavir nonadherence and dose-staggering in recipients of boosted HIV-1 protease inhibitor therapy.
    Shuter J; Sarlo JA; Rode RA; Zingman BS
    HIV Clin Trials; 2009; 10(3):135-42. PubMed ID: 19632952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of virologic failure in HIV-1-infected patients starting highly active antiretroviral therapy in Porto Alegre, Brazil.
    Tuboi SH; Harrison LH; Sprinz E; Albernaz RK; Schechter M
    J Acquir Immune Defic Syndr; 2005 Nov; 40(3):324-8. PubMed ID: 16249707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
    Braithwaite RS; Kozal MJ; Chang CC; Roberts MS; Fultz SL; Goetz MB; Gibert C; Rodriguez-Barradas M; Mole L; Justice AC
    AIDS; 2007 Jul; 21(12):1579-89. PubMed ID: 17630553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.